Suppr超能文献

新型正电子发射断层扫描显像剂[C]UCB-J 用于突触囊泡糖蛋白 2A 的动力学评估及其在人体中的重测信度研究。

Kinetic evaluation and test-retest reproducibility of [C]UCB-J, a novel radioligand for positron emission tomography imaging of synaptic vesicle glycoprotein 2A in humans.

机构信息

1 Department of Radiology and Biomedical Imaging, Yale Positron Emission Tomography Center, Yale University, New Haven, CT, USA.

2 UCB Pharma, B-1420 Braine-l'Alleud, Belgium.

出版信息

J Cereb Blood Flow Metab. 2018 Nov;38(11):2041-2052. doi: 10.1177/0271678X17724947. Epub 2017 Aug 9.

Abstract

Synaptic vesicle glycoprotein 2A (SV2A) is ubiquitously present in presynaptic terminals. Here we report kinetic modeling and test-retest reproducibility assessment of the SV2A positron emission tomography (PET) radioligand [C]UCB-J in humans. Five volunteers were examined twice on the HRRT after bolus injection of [C]UCB-J. Arterial blood samples were collected for measurements of radiometabolites and free fraction. Regional time-activity curves were analyzed with 1-tissue (1T) and 2-tissue (2T) compartment models to estimate volumes of distribution ( V). Parametric maps were generated using the 1T model. [C]UCB-J metabolized fairly quickly, with parent fraction of 36 ± 13% at 15 min after injection. Plasma free fraction was 32 ± 1%. Regional time-activity curves displayed rapid kinetics and were well described by the 1T model, except for the cerebellum and hippocampus. V values estimated with the 2T model were similar to 1T values. Parametric maps were of high quality and V values correlated well with time activity curve (TAC)-based estimates. Shortening of acquisition time from 120 min to 60 min had a negligible effect on V values. The mean absolute test-retest reproducibility for V was 3-9% across regions. In conclusion, [C]UCB-J exhibited excellent PET tracer characteristics and has potential as a general purpose tool for measuring synaptic density in neurodegenerative disorders.

摘要

突触小泡糖蛋白 2A(SV2A)在突触前末梢中普遍存在。在这里,我们报告了 SV2A 正电子发射断层扫描(PET)配体 [C]UCB-J 在人类中的动力学建模和测试-再测试重现性评估。在 HRRT 上进行静脉注射 [C]UCB-J 后,有 5 名志愿者进行了两次检查。采集动脉血样以测量放射性代谢产物和游离分数。使用 1 组织(1T)和 2 组织(2T)室模型分析区域时间-活性曲线,以估计分布体积(V)。使用 1T 模型生成参数图。[C]UCB-J 代谢相当快,注射后 15 分钟时母体分数为 36±13%。血浆游离分数为 32±1%。除小脑和海马体外,区域时间-活性曲线显示出快速的动力学,并且可以很好地用 1T 模型来描述。使用 2T 模型估计的 V 值与 1T 值相似。参数图质量很高,V 值与基于时间活性曲线(TAC)的估计值相关性良好。将采集时间从 120 分钟缩短至 60 分钟对 V 值几乎没有影响。V 值的平均绝对测试-再测试重现性在各区域为 3-9%。总之,[C]UCB-J 表现出优异的 PET 示踪剂特性,有望成为测量神经退行性疾病中突触密度的通用工具。

相似文献

2
Kinetics and 28-day test-retest repeatability and reproducibility of [C]UCB-J PET brain imaging.
J Cereb Blood Flow Metab. 2021 Jun;41(6):1338-1350. doi: 10.1177/0271678X20964248. Epub 2020 Oct 8.
4
In vivo imaging of synaptic density with [C]UCB-J PET in two mouse models of neurodegenerative disease.
Neuroimage. 2021 Oct 1;239:118302. doi: 10.1016/j.neuroimage.2021.118302. Epub 2021 Jun 23.
5
Validation and noninvasive kinetic modeling of [C]UCB-J PET imaging in mice.
J Cereb Blood Flow Metab. 2020 Jun;40(6):1351-1362. doi: 10.1177/0271678X19864081. Epub 2019 Jul 15.
6
First-in-Human Evaluation of F-SynVesT-1, a Radioligand for PET Imaging of Synaptic Vesicle Glycoprotein 2A.
J Nucl Med. 2021 Apr;62(4):561-567. doi: 10.2967/jnumed.120.249144. Epub 2020 Aug 28.
7
Assessment of test-retest reproducibility of [F]SynVesT-1, a novel radiotracer for PET imaging of synaptic vesicle glycoprotein 2A.
Eur J Nucl Med Mol Imaging. 2021 May;48(5):1327-1338. doi: 10.1007/s00259-020-05149-3. Epub 2021 Jan 8.
9
Quantifying SV2A density and drug occupancy in the human brain using [C]UCB-J PET imaging and subcortical white matter as reference tissue.
Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):396-406. doi: 10.1007/s00259-018-4119-8. Epub 2018 Aug 18.
10
Autoradiographic mapping of synaptic vesicle glycoprotein 2A in non-human primate and human brain.
Synapse. 2020 Oct;74(10):e22157. doi: 10.1002/syn.22157. Epub 2020 Apr 19.

引用本文的文献

2
Synaptic Density in Multiple Sclerosis: An In Vivo Study Using [C]UCB-J-PET Imaging.
Neurol Neuroimmunol Neuroinflamm. 2025 Sep;12(5):e200435. doi: 10.1212/NXI.0000000000200435. Epub 2025 Jul 3.
6
Network-based Molecular Constraints on Synaptic Density Alterations in Schizophrenia.
medRxiv. 2025 Mar 23:2025.03.22.25324465. doi: 10.1101/2025.03.22.25324465.
7
Advances in synaptic PET imaging and intervention with synapse-targeted small-molecular drugs for dementia diagnosis and therapy.
Fundam Res. 2024 Apr 21;5(1):63-71. doi: 10.1016/j.fmre.2024.04.013. eCollection 2025 Jan.
8
Imaging Synaptic Density in Aging and Alzheimer Disease with [F]SynVesT-1.
J Nucl Med. 2025 Apr 1;66(4):620-625. doi: 10.2967/jnumed.124.269005.

本文引用的文献

2
Imaging synaptic density in the living human brain.
Sci Transl Med. 2016 Jul 20;8(348):348ra96. doi: 10.1126/scitranslmed.aaf6667.
3
[(11)C]UCB-A, a novel PET tracer for synaptic vesicle protein 2A.
Nucl Med Biol. 2016 Jun;43(6):325-32. doi: 10.1016/j.nucmedbio.2016.03.004. Epub 2016 Mar 17.
6
Test-retest reproducibility of the metabotropic glutamate receptor 5 ligand [¹⁸F]FPEB with bolus plus constant infusion in humans.
Eur J Nucl Med Mol Imaging. 2015 Sep;42(10):1530-41. doi: 10.1007/s00259-015-3094-6. Epub 2015 Jun 5.
7
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice.
Ann Neurol. 2015 Jun;77(6):953-71. doi: 10.1002/ana.24394. Epub 2015 Mar 21.
8
Biodistribution and Radiation Dosimetry for the Novel SV2A Radiotracer [(18)F]UCB-H: First-in-Human Study.
Mol Imaging Biol. 2015 Aug;17(4):557-64. doi: 10.1007/s11307-014-0820-6.
10
Radiosynthesis of (11)C-Levetiracetam: A Potential Marker for PET Imaging of SV2A Expression.
ACS Med Chem Lett. 2014 Aug 19;5(10):1152-5. doi: 10.1021/ml500285t. eCollection 2014 Oct 9.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验